Skip to content
DataLookout
Menu

ClinicalTrials.gov term: Pulmonary Disease, Chronic Obstructive

COPD clinical trials

Get alerts when COPD trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08

What changed in the last 30 days

77 trials changed in the last 30 days: 2 stopped, 32 with notable changes, 43 with minor changes only.

  1. Minor: 13 trials marked Unknown by the registry's verification sweep Changed Registry verification sweep13 trials
    1. Minor: QUANTUM · Quest to Analyze One Thousand Humans Meditating Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation Tobias Moeller-BertramNot specified NCT06583395
    2. Minor: Use of Diaphragmatic Ultrasonography in Mechanical Ventilation Weaning Decision in COPD Patient Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Tanta UniversityNot applicable NCT07082361
    3. Minor: Impact of HI-NPPV Vs LI-NPPV on Tolerance Among AECOPD Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Beijing Chao Yang HospitalNot applicable NCT06692023
    4. Minor: Presentation and Outcome of COPD · Acute Exacerbation Attending Sohag University Hospital Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Sohag UniversityNot specified NCT06684353
    5. Minor: Telerehabilitation · Chronic Obstructive Pulmonary Disease in Nuuk Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Steno Diabetes Center GreenlandNot specified NCT06660589
    6. Minor: EntMedPall · Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting University Hospital MuensterNot applicable NCT06648733
    7. Minor: Transbronchial Bronchoscopic Thermal Vapor Ablation (BTVA) in Heterogeneous Emphysema Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Ye GuNot specified NCT06642038
    8. Minor: Breather in COPD · Intermittent Claudication Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Cairo UniversityNot applicable NCT06529185
    9. Minor: Bufei Yishen Prescription on · Frequent AECOPD in Stable Stage Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Not Yet Recruiting Henan University of Traditional Chinese MedicineNot applicable NCT06326658
    10. Minor: Air Filtration for COPD in VA Population of Veterans Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting Illinois Institute of TechnologyNot applicable NCT05913765
    11. Minor: UNDATED · Sonographic Diaphragm Function in AECOPD Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting IsalaNot specified NCT05671198
    12. Minor: Telerehabilitation in COPD Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research HospitalNot applicable NCT05053061
    13. Minor: COPD-SAFE · Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research HospitalNot applicable NCT04089111
  2. Notable: THERMA-LUNG · THERMotherapy Against Persistent Bacterial LUNG Infections Primary and study completion pushed from Dec 31, 2029 to Oct 31, 2032 Chronic Obstructive Pulmonary Disease Trial Network, DenmarkNot applicable NCT05351242
  3. Notable: ENHANCE-3 · Ensifentrine (MK-5884) Study · Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3) Recruitment opened Merck Sharp & Dohme LLCPhase 3 NCT07874815
  4. Notable: LANDCAP-1 · Local Antibiotic Delivery for Community Acquired Pneumonia Primary completion date changed from estimate of Sep 1, 2025 to Mar 17, 2026 Copenhagen Respiratory ResearchPhase 2/3 NCT06859450
  5. Minor: Symptoms and Functions · COPD and Chronic Bronchitis Switching From CIG to THS Primary completion pushed from Aug 2026 to Feb 2027 Philip Morris Products S.A.Not applicable NCT07108166
  6. Minor: SCALA · 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study · Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis Trial sites expanded: 23 → 26 locations UCB Biopharma SRLPhase 2 NCT07725939
  7. Minor: CHRONOBIO · Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) Study completion pushed from Jul 1, 2026 to Mar 1, 2027 Michaël RACODONNot applicable NCT06366113
  8. Notable: Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery Primary completion pushed from Jul 2027 to Jul 2028 François LelloucheNot applicable NCT04136717
  9. Notable: Interfaces · Several Oxygenation Targets With Different Oxygen Interfaces - Impact on Oxygen Flow Rates Primary completion pushed from Jun 2025 to Jun 2027 Laval UniversityNot applicable NCT06646991
  10. Minor: GSK5784283 (Felcorekibart) Compared With Placebo · Moderate to Very Severe COPD (PERSIST COPD-2) Trial sites expanded: 4 → 8 locations GlaxoSmithKlinePhase 3 NCT07780656
  11. Minor: GSK5784283 (Felcorekibart) Compared With Placebo · Moderate to Very Severe COPD (PERSIST COPD-1) Trial sites expanded: 2 → 7 locations GlaxoSmithKlinePhase 3 NCT07780669
  12. Minor: WINDSURFER · WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department Trial sites expanded: 6 → 9 locations Ohio State UniversityNot applicable NCT07558265
  13. Notable: Impact of Maximal Strength Training · COPD Primary completion pushed from May 30, 2026 to Feb 28, 2027 Istituti Clinici Scientifici Maugeri SpANot applicable NCT03799354
  14. Notable: NAPOLEON · Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project Primary completion pushed from Oct 2026 to Oct 2027 Institut de Recerca Biomèdica de LleidaNot applicable NCT07394712
  15. Notable: Ensifentrine (MK-5884/RPL554) on Sputum Markers of Inflammation in Chronic Obstructive Pulmonary Disease (COPD) (MK-5884-023/RPL554-CO-207) Primary endpoint(s) modified Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USAPhase 2 NCT05270525
  16. Notable: OVERMUSCLED · Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea · Chronic Respiratory Disease: a Randomized Cross-over Trial Recruitment opened Fondation Hôpital Saint-JosephNot applicable NCT06811402
  17. Minor: INSPIRE-COPD-E · Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations Primary completion pushed from Sep 1, 2028 to Feb 1, 2029 Duke UniversityPhase 1 NCT07275359
  18. Minor: Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES) Start date changed from estimate of Nov 4, 2026 to Oct 28, 2026 National Institute of Allergy and Infectious Diseases (NIAID)Not specified NCT07867184
  19. Minor: Patients With COPD and PRISM Trial completed Karabuk UniversityNot specified NCT07249567
  20. Notable: AERODUO-2 · AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients Recruitment opened AeroRx Therapeutics Inc.Phase 2 NCT07896252
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-11-03 NCT07914010 Reducing Exposure With Air Cleaners and Technology University of California, Berkeley new
2026-11-02 NCT07908381 A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in… Enanta Pharmaceuticals, Inc new Phase 2/3
2026-10-21 NCT07886346 COPD Prevalence and Risk Factors Among Saudi Adults Over 18 in Taif Taif University new
2026-10-21 NCT07886502 Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High… Klinikum Dortmund Wirbelsäulenchirurgie new
2026-10-13 NCT07871357 Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD Bryan A. Ross new Phase 2
2026-10-09 NCT07868211 Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters… Júnea Regina Pires Drews new
2026-10-09 NCT07867184 Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES) National Institute of Allergy and Infectious Diseases (NIAID) new
2026-10-02 NCT07854210 HFNC Versus NIV in Hypercapneic COPD Patients Mohammed Shehta new
2026-10-02 NCT07856667 COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease VASCage GmbH new
2026-10-01 NCT07852910 Indoor Overheating and Physiological Strain in Older Adults With COPD University of Ottawa new

Active trials by phase

Early Phase 1
4
Phase 1
18
Phase 1/2
12
Phase 2
49
Phase 2/3
8
Phase 3
37
Phase 4
31
Not charted: 665 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when COPD trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials